Qomel Company Limited

SR 31.98As of Sun 8 Nov 2026, 12:00 UTC
Tadawul:9600Healthcare
Country Saudi Arabia
PE (Fwd) •••
TSR 2Y CAGR (6.32%)
Div yield —
ROE 5.63%
Medical (Pharmaceuticals)
Beta (5Y) 0.72
PE TTM 33.15
TSR TTM (36.67%)
Mkt cap SR 223.9M
ROIC 6.51%
SE Grade™
Value
Quality
Moat
Consensus
Reference
SR 33
1.79%
(9.62%)
Hold 2|1|7|1|2
4Q25
1Q26
2Q26
3Q26
Earnings per shareSR
0.54
0.56
0.61
0.68
16.13%
18.56%
19.16%
25.77%
RevenueSR M
11.97
11.95
11.64
11.31
0.30%
(2.93%)
(3.32%)
(3.60%)
Peers (US$65.44M)
Cap (US$)
PE
67.70M
—
Capital
TTM
5Y
10Y
Leveragex
0.206
0.255
0.236
EBIT/Intx
13.46
1.680
1.472
Own earn%
132.20
(81.67)
(63.14)
Sh yield%
21.84
42.96
43.05
Owners
Insiders/Inst%
9.49
56.23
Short interest%
3.37
SBC / revenue%
1.53
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
25–31
$1 testx
0.0
Incr. ROIC%
−2